<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi>-dependent insulinotropic <z:chebi fb="1" ids="15841">polypeptide</z:chebi> (GIP) potentiates <z:chebi fb="105" ids="17234">glucose</z:chebi>-stimulated insulin secretion (GSIS) </plain></SENT>
<SENT sid="1" pm="."><plain>This response is blunted in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (T2DM) </plain></SENT>
<SENT sid="2" pm="."><plain>Xenin-25 is a 25-amino acid <z:chebi fb="0" ids="7542">neurotensin</z:chebi>-related <z:chebi fb="7" ids="16670">peptide</z:chebi> that amplifies GIP-mediated GSIS in hyperglycemic mice </plain></SENT>
<SENT sid="3" pm="."><plain>This study determines if xenin-25 amplifies GIP-mediated GSIS in humans with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT), <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT), or T2DM </plain></SENT>
<SENT sid="4" pm="."><plain>Each fasting subject received graded <z:chebi fb="105" ids="17234">glucose</z:chebi> infusions to progressively raise plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations, along with vehicle alone, GIP, xenin-25, or GIP plus xenin-25 </plain></SENT>
<SENT sid="5" pm="."><plain>Plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin, C-<z:chebi fb="7" ids="16670">peptide</z:chebi>, and glucagon levels and insulin secretion rates (ISRs) were determined </plain></SENT>
<SENT sid="6" pm="."><plain>GIP amplified GSIS in <z:hpo ids='HP_0000001'>all</z:hpo> groups </plain></SENT>
<SENT sid="7" pm="."><plain>Initially, this response was rapid, profound, transient, and essentially <z:chebi fb="105" ids="17234">glucose</z:chebi> independent </plain></SENT>
<SENT sid="8" pm="."><plain>Thereafter, ISRs increased as a function of plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>Although magnitudes of insulin secretory responses to GIP were similar in <z:hpo ids='HP_0000001'>all</z:hpo> groups, ISRs were not restored to <z:mpath ids='MPATH_458'>normal</z:mpath> in subjects with IGT and T2DM </plain></SENT>
<SENT sid="10" pm="."><plain>Xenin-25 alone had no effect on ISRs or plasma glucagon levels, but the combination of GIP plus xenin-25 transiently increased ISR and plasma glucagon levels in subjects with NGT and IGT but not T2DM </plain></SENT>
<SENT sid="11" pm="."><plain>Since xenin-25 signaling to islets is mediated by a cholinergic relay, impaired islet responses in T2DM may reflect defective neuronal, rather than GIP, signaling </plain></SENT>
</text></document>